Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Diagnosis and Management of Cutaneous Candidiasis in Bedridden Patients

Diagnostic Approach

  • Aggressively evaluate skin lesions through culture aspiration, biopsy, or surgical excision as they may be caused by resistant microbes, yeast, or molds 1
  • Serum fungal antigen tests (1,3-β-D-glucan or galactomannan) have low sensitivity, particularly in patients already receiving antifungal agents 1
  • Consider imaging studies (CT, MRI, ultrasound) if blood cultures are persistently positive for Candida species 3
  • Recovery of fungi from aspiration or biopsy of skin warrants aggressive systemic antifungal therapy 4

Management Protocol

  • First-line therapy for systemic or disseminated candidiasis is an echinocandin (caspofungin: 70 mg loading dose, then 50 mg daily; micafungin: 100 mg daily; or anidulafungin: 200 mg loading dose, then 100 mg daily) 5
  • Alternative therapy for systemic or disseminated candidiasis is fluconazole 800 mg (12 mg/kg) loading dose, then 400 mg (6 mg/kg) daily for patients unlikely to have fluconazole-resistant Candida species 5
  • For chronic disseminated candidiasis, initial therapy with lipid formulation AmB (3-5 mg/kg daily) or an echinocandin for several weeks, followed by oral fluconazole 400 mg daily 2
  • Continue therapy until lesions resolve on repeat imaging, which usually takes several months 2

Special Considerations

  • For fluconazole-resistant species (C. krusei, C. glabrata), use an echinocandin, lipid formulation AmB, or voriconazole 6
  • Surgical treatment should be considered for patients with skin and soft tissue changes caused by angioinvasive molds (Mucor, Rhizopus, Aspergillus) 4
  • For patients with debilitating persistent fevers, short-term (1-2 weeks) treatment with nonsteroidal anti-inflammatory drugs or corticosteroids can be considered 2

Clinical Variants of Candidiasis in Bedridden Patients

  • Discrete pink to red papules (0.5-1.0 cm) usually found on trunk and extremities 4
  • Lesions may develop central pallor or become hemorrhagic 4
  • Up to 13% of patients with invasive disseminated candidiasis develop single or multiple nodular skin lesions 4
  • Painful myositis is most common with Candida tropicalis infection 4
  • Muscle and soft tissue abscess formation is uncommon but may occur following immune recovery 4
  • Trichosporon beigelii infection can mimic candidiasis with multiple erythematous macules to maculopapular lesions 4
  • Cutaneous mold infections may resemble ecthyma gangrenosum due to angioinvasion 4

Prevention Strategies

  • Daily bathing with chlorhexidine for bedridden patients to decrease the incidence of bloodstream infections 6

Common Pitfalls and Caveats

  • Premature discontinuation of antifungal therapy can lead to relapse 2
  • Fluconazole-resistant yeast (C. krusei and C. glabrata) are increasingly common due to widespread use of azole prophylaxis 4